CN110495604A - Plant element composition and its producing method - Google Patents
Plant element composition and its producing method Download PDFInfo
- Publication number
- CN110495604A CN110495604A CN201811286805.1A CN201811286805A CN110495604A CN 110495604 A CN110495604 A CN 110495604A CN 201811286805 A CN201811286805 A CN 201811286805A CN 110495604 A CN110495604 A CN 110495604A
- Authority
- CN
- China
- Prior art keywords
- finished
- semi
- phytochemicals
- filling
- grade
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 6
- 238000000034 method Methods 0.000 title abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 34
- 230000000694 effects Effects 0.000 claims abstract description 18
- 150000003384 small molecules Chemical class 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 238000001514 detection method Methods 0.000 claims description 33
- 235000017807 phytochemicals Nutrition 0.000 claims description 33
- 229930000223 plant secondary metabolite Natural products 0.000 claims description 33
- 239000000470 constituent Substances 0.000 claims description 25
- 239000000047 product Substances 0.000 claims description 25
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims description 24
- 238000011049 filling Methods 0.000 claims description 24
- 238000004659 sterilization and disinfection Methods 0.000 claims description 24
- 238000001816 cooling Methods 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 17
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 16
- 238000012360 testing method Methods 0.000 claims description 16
- 229940024606 amino acid Drugs 0.000 claims description 12
- 235000001014 amino acid Nutrition 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 10
- 150000001412 amines Chemical class 0.000 claims description 10
- 238000005538 encapsulation Methods 0.000 claims description 10
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 9
- 235000004279 alanine Nutrition 0.000 claims description 9
- 230000000844 anti-bacterial effect Effects 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- 238000005070 sampling Methods 0.000 claims description 9
- 239000004475 Arginine Substances 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 8
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 8
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 8
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 8
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 8
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 8
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 8
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 8
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 8
- 229960000310 isoleucine Drugs 0.000 claims description 8
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 8
- 239000004474 valine Substances 0.000 claims description 8
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 241000208340 Araliaceae Species 0.000 claims description 6
- 244000019459 Cynara cardunculus Species 0.000 claims description 6
- 235000019106 Cynara scolymus Nutrition 0.000 claims description 6
- 235000003230 Helianthus tuberosus Nutrition 0.000 claims description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 229930182817 methionine Natural products 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 240000008397 Ganoderma lucidum Species 0.000 claims description 5
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 5
- 244000197580 Poria cocos Species 0.000 claims description 5
- 235000008599 Poria cocos Nutrition 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- 230000003197 catalytic effect Effects 0.000 claims description 5
- 230000009920 chelation Effects 0.000 claims description 5
- 239000012491 analyte Substances 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000006041 probiotic Substances 0.000 claims description 3
- 235000018291 probiotics Nutrition 0.000 claims description 3
- 239000011265 semifinished product Substances 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- QWWVBNODQCWBAZ-WHFBIAKZSA-N (2r)-2-amino-3-[(2r)-2-carboxy-2-(methylamino)ethyl]sulfanylpropanoic acid Chemical compound CN[C@H](C(O)=O)CSC[C@H](N)C(O)=O QWWVBNODQCWBAZ-WHFBIAKZSA-N 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 241001251949 Xanthium sibiricum Species 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 14
- 210000000232 gallbladder Anatomy 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 abstract description 2
- 108010012715 Superoxide dismutase Proteins 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000035790 physiological processes and functions Effects 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 229910001385 heavy metal Inorganic materials 0.000 abstract 1
- 230000006870 function Effects 0.000 description 9
- 241000411851 herbal medicine Species 0.000 description 7
- 238000007689 inspection Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 230000004913 activation Effects 0.000 description 5
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000007449 liver function test Methods 0.000 description 2
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a plant element composition and its preparation method, it includes the step of preparing the raw materials, step of small molecule, batching step, mixing step and thermostatical stewing step, finish the finished product through the above-mentioned process step, therefore, make the plant element composition of the invention have high content of superoxide dismutase activity, and heavy metal content and living bacterium number content are low, can guarantee the safety after human being taken, and have high degerming rate, and can further promote the health of the function of liver and gallbladder, make the human physiological function more activating collaterals, increase immunity and can keep healthy often, keep away from the disease.
Description
Technical field
The present invention is related with a kind of constituent of Chinese herbal medicine and its manufacturing method, particularly relates to a kind of to promote liver and gallbladder function
Phytochemicals constituent and its manufacturing method.
Background technique
Chinese medicine refers under traditional Chinese medical theory basis, for preventing or treating the natural product and processed goods of disease；Herbal medicine is then
Refer to and do not add to record, spreads civil herbaceous plant.Chinese herbal medicine in a narrow sense then refers to the plant origin with therapeutic effect, also
It can be described as botanical medicine, since aging society structure is formed in recent years, chronic disease incidence rises year by year, and modern increasingly likes
It is taken after natural Chinese herbal medicine is worn into powdery, sheet or decoction of medicinal ingredients well, to raise body, promotes health.
Though common people are mistakenly considered its pharmacological property must be mild, safe and non-toxic however, Chinese herbal medicine belongs to natural origin.However medium-height grass
Medicine itself may contain toxic substance, merge with other therapeutic agents in use, often generating phase interaction if careless slightly
With, or even generate various adverse reactions or toxic reaction.In addition, medicinal herb components are complicated, the drug of many Chinese herbal medicines and without
Close control is crossed, the content of effective component is unstable or is not easy to determine, therefore takes rear effect not as good as expection.Therefore, existing
Chinese herbal medicine composition and its manufacturing method still have further improved necessity.
Summary of the invention
In view of this, having the main purpose of the present invention is to provide a kind of phytochemicals constituent and its manufacturing method
Stable manufacturing method and active constituent content, can promote human health.
In order to reach above-mentioned purpose, phytochemicals manufacturing method provided by the present invention, it includes have the following steps:
Material preparation step: preparing a plurality of raw materials, which includes Radix Glycyrrhizae, ginseng, ganoderma lucidum, fructus lycii, globe artichoke and Poria cocos；
Small molecule step: the grade raw materials are put into a catalytic unit with by the grade raw materials small molecule；
Batching step: the raw material after small molecule is subjected to ingredient to scale；
Mixing step: the raw material after ingredient is heated to sterilize, and be stirred within 0.5~3 hour, by this
Etc. raw material decomposes be have amino acid semi-finished product；
Constant temperature stands step: semi-finished stock being stood 30 days~180 days, converts the grade semi-finished stocks voluntarily, is promoted
So that it is converted to amino acid and polypeptide, small-molecular peptides into raw material decomposes, promotes absorption of human body.
Preferably, wherein in mixing step, the raw material after ingredient is added into the water of 5wt%~15wt% and is added
Heat, to be sterilized, while adding the probiotics of 1wt%~5wt% to 100 DEG C, ionizes the grade raw materials.
Preferably, wherein after mixing step, further included a cooling step: semi-finished stock is cooled to
30 DEG C~50 DEG C, after cooling step, further include a chelation step: by the semi-finished stock tinning after cooling, and with 30
DEG C~stirring of 50 DEG C of constant temperature carries out chelating conversion reaction.
Preferably, wherein after chelation step, further included a first time plasma air sterilisation step:
By the semi-finished stock after tinning in standing space with plasma air bactericidal purifying workshop, after constant temperature stands step, more
Include a sampling Detection step: the grade semi-finished stocks being sampled detection, sampling Detection project includes total hydrolysis ammonia
Base acid forms analyte detection, SOD like activity content detection, content of beary metal detection, aerobic plate count detection and antibacterial
Testing inspection further includes second of plasma air sterilisation step after sampling Detection step: by being somebody's turn to do for filling space
Equal semi-finished stocks are in standing space with plasma air bactericidal purifying workshop.
Preferably, wherein after second of plasma air sterilisation step, further included assembly line encapsulation
Step: carrying out assembly line encapsulation for the equal semi-finished stocks of filling this, after assembly line encapsulation step, further included one it is filling at
Product step: filling finished product is made in the grade semi-finished stocks after assembly line is encapsulated, which is liquid, glue, powdery
Or ingot shape has further included a steam sterilization step after filling finished product step: by filling finished product with 100 DEG C of steam sterilizations, Yu Zheng
After gas sterilisation step, a packed products step is further included: the filling finished product after sterilization is packed.
Preferably, wherein after second of plasma air sterilisation step, further included misting cooling step
It is rapid: by the filling grade semi-finished stocks to carry out being cooled to powder by spraying, and after the misting cooling step, to have further included
One encapsulation finished product step: the grade semi-finished stocks after cooling are encapsulated as finished product.
In order to achieve the above object, phytochemicals constituent provided by the present invention, raw material includes Radix Glycyrrhizae, ginseng, ganoderma lucidum, Chinese holly
Qi, globe artichoke and Poria cocos, which includes: Tian Men Dong Hai amine, bran propylhomoserin, serine, histidine, glycine,
Crisp propylhomoserin, arginine, alanine, tyrosine, valine, methionine, isoleucine, leucine, from propylhomoserin and proline.
Preferably, wherein the every 100mL of the phytochemicals constituent includes: Tian Men Dong Hai amine (150-165mg),
Bran propylhomoserin (65-75mg), serine (5-15mg), histidine (0.5-2mg), glycine (5-15mg), crisp propylhomoserin (2.5-
7.5mg), arginine (10-20mg), alanine (15-25mg), tyrosine (2-5mg), valine (7-17mg), methionine
(3-8mg), isoleucine (1-5mg), leucine (2-8mg), from propylhomoserin (0.5-4.5mg) and proline (10-30mg).
Preferably, wherein the phytochemicals constituent has effects that promote liver and gallbladder function and high degerming rate.
Phytochemicals constituent provided by the present invention and its manufacturing method, the Like superoxide dismutase with high-content
Activity, content of beary metal and aerobic plate count content are low, and have high degerming rate, and can further promote the health of liver and gallbladder function, allow
Human physiological functions are more active, increase immunity and can Chang Baojian health, far from disease.
Detailed description of the invention
Fig. 1 is the flow chart of the first preferred embodiment of the invention.
Fig. 2 is the flow chart of the second preferred embodiment of the invention.
Specific embodiment
In order to have a better understanding and awareness to the purpose of the present invention, feature and effect, please cooperate below
Bright book attached drawing is described in detail as after.
Refering to Figure 1, being the flow chart of the first preferred embodiment of the invention, announcement has a kind of phytochemicals to manufacture
Method, it includes have the following steps:
Material preparation step: preparing a plurality of raw materials, which includes Radix Glycyrrhizae, ginseng, ganoderma lucidum, fructus lycii, globe artichoke and Poria cocos,
The equal raw materials can be packaging, packed or barreled prototype, slice or stripping and slicing state.
Small molecule step: the grade raw materials are put into a catalytic unit with by the grade raw materials small molecule, the catalytic unit
For an activation equipment, which has an emitter, the releasable electromagnetic wave of the catalytic unit, thus this waits raw materials to can absorb electromagnetism
Wave further speeds up the movement of the molecular structure of the grade raw materials, and the intermolecular activity is made to be substantially improved, and then improve this etc.
The amalgamation of raw material, and can reach the effect of activation, in addition, the irradiation of the electromagnetic wave is the activation method of Noninvasive, it can be just
In controlling the activation degree for waiting raw materials, to maintain the quality after grade raw materials activation.
Batching step: by the raw material after small molecule according to Radix Glycyrrhizae 20wt%~30wt%, ginseng 5wt%~12wt%, spirit
Sesame 20wt%~30wt%, fructus lycii 5wt%~15wt%, globe artichoke 15wt%~25wt% and Poria cocos 20wt%~30wt%
Ratio carry out ingredient.
Mixing step: adding the water of 5wt%~15wt% for the raw material after ingredient and is heated to 100 DEG C to sterilize,
The probiotics of 1wt%~5wt%, such as acetic acid bacteria and lactic acid bacteria are added simultaneously, are ionized the grade raw materials, are finally carried out 0.5
The raw material decomposes such as this are the semi-finished product for having amino acid by~3 hours be stirred, in the embodiment of the present invention, amino acid packet
The Dong Hai of Men containing Tian amine, bran propylhomoserin, serine, histidine, glycine, crisp propylhomoserin, arginine, alanine, tyrosine, valine,
Methionine, isoleucine, leucine, from propylhomoserin and proline.
Cooling step: semi-finished stock is cooled to 30 DEG C~50 DEG C.
Chelation step: by the semi-finished stock tinning after cooling, and chelating is carried out with 30 DEG C~50 DEG C constant temperature stirrings and is turned
Change reaction.
First time plasma air sterilisation step: the semi-finished stock after tinning is empty with plasma in standing space
Hopping mad bacterium cleaning shop (using air pump by the air in workshop by a pdp filter device, makes the workshop Shi Xianrang that is switched on
Interior clump count reduces, and achievees the effect that purification, reduces contaminated chance).
Constant temperature stands step: the tinning semi-finished stock after sterilization being stood 30 days~180 days, makes the grade semi-finished stocks
It voluntarily converts, promotes raw material decomposes that it is made to be converted to amino acid and polypeptide, small-molecular peptides, promote absorption of human body.
Sampling Detection step: the grade semi-finished stocks are sampled detection, sampling Detection project includes total hydrolysis ammonia
Base acid forms analyte detection, SOD like activity content detection, content of beary metal detection, aerobic plate count detection and antibacterial
Testing inspection.
It is being entrusted with sample to enable its result of sampling inspection of phytochemicals manufacturing method of the invention to obtain trust and receiving
Tuo Dufu Rhein limited liability company, laboratory, Kaohsiung is detected for above-mentioned sampling content, as a result as follows:
Total hydrolysis amino acid (Total hydrolyzed amino acids) forms analyte detection:
| Detection project | As a result |
| Its Dong Hai amine | 157.85mg/100mL |
| Bran propylhomoserin | 68.27mg/100mL |
| Serine | 9.87mg/100mL |
| Histidine | 1.15mg/100mL |
| Glycine | 11.17mg/100mL |
| Crisp propylhomoserin | 5.00mg/100mL |
| Arginine | 16.61mg/100mL |
| Alanine | 18.04mg/100mL |
| Tyrosine | 3.34mg/100mL |
| Valine | 12.20mg/100mL |
| Methionine | 4.49mg/100mL |
| Isoleucine | 2.20mg/100mL |
| Leucine | 3.57mg/100mL |
| From propylhomoserin | 1.97mg/100mL |
| Proline | 20.50mg/100mL |
| Summation | 336.22mg/100mL |
| Detection method | Amino acid assays chamber interior method (HPLC-FLD) |
SOD like activity content detection:
By above-mentioned testing result, it can be seen that, this of the invention waits semi-finished stocks, the class superoxides with high-content
Dismutase activity (SOD-like activity).
Content of beary metal detection:
By above-mentioned testing result, it can be seen that, the equal semi-finished stocks of the invention, content of beary metal is low, ensures that human body is strong
Health.
Aerobic plate count detection:
By above-mentioned testing result, it can be seen that, the equal semi-finished stocks of the invention, aerobic plate count content is low, ensures that human body is strong
Health.
Antibacterial tests detection-Salmonella:
By above-mentioned testing result, it can be seen that, the equal semi-finished stocks of the invention can effectively reduce Salmonella
Bacterium number, degerming rate is up to 99.99%, and can promote stomach health.
Antibacterial tests detection-staphylococcus aureus:
By above-mentioned testing result, it can be seen that, the equal semi-finished stocks of the invention can effectively reduce Staphylococcus aureus
The bacterium number of bacterium, degerming rate is up to 96.94%, and can promote stomach health.
Second of plasma air sterilisation step: by the equal semi-finished stocks of filling space in stand space with it is equal from
Daughter air disinfection cleaning shop is (first when making to be switched on using air pump by the air in workshop by a pdp filter device
It allows the clump count in workshop to reduce, achievees the effect that purification, reduce contaminated chance).
Assembly line encapsulation step: the filling equal semi-finished stocks are subjected to assembly line encapsulation.
Filling finished product step: the grade semi-finished stocks after assembly line is encapsulated are made filling finished product, finished product can for liquid,
Gluey, powdery or ingot shape.
Steam sterilization step: by filling finished product with 100 DEG C of steam sterilizations.
Packed products step: the filling finished product after sterilization is packed.
Through the phytochemicals manufacturing method step of aforementioned present invention, and a kind of phytochemicals constituent can be obtained, the wherein plant
The every 100mL of object promotor composition includes: Tian Men Dong Hai amine (150-165mg), bran propylhomoserin (65-75mg), serine (5-15mg),
Histidine (0.5-2mg), glycine (5-15mg), crisp propylhomoserin (2.5-7.5mg), arginine (10-20mg), alanine (15-
25mg), tyrosine (2-5mg), valine (7-17mg), methionine (3-8mg), isoleucine (1-5mg), leucine (2-
8mg), from propylhomoserin (0.5-4.5mg) and proline (10-30mg).
For further understandings of construction feature of the present invention, application technology means and desired the effect of reaching, hereby this is sent out
Bright usage mode is described, it is believed that when that can have deeper into the present invention therefrom and specifically understand, as described below:
In presently preferred embodiments of the present invention, the every 100mL of the phytochemicals constituent includes: Tian Men Dong Hai amine
(157.85mg), bran propylhomoserin (68.27mg), serine (9.87mg), histidine (1.15mg), glycine (11.17mg), crisp ammonia
Acid (5.00mg), arginine (16.61mg), alanine (18.04mg), tyrosine (3.34mg), valine (12.20mg), first
Methyllanthionine (4.49mg), isoleucine (2.20mg), leucine (3.57mg), from propylhomoserin (1.97mg) and proline
(20.50mg)。
The phytochemicals constituent of the invention has effects that following:
One, with the SOD like activity of high-content, it can promote human health.
Two, content of beary metal and aerobic plate count content are low, can ensure the safety after human body is taken.
Three, there is high degerming rate, the bacterium number of Salmonella and staphylococcus aureus can be effectively removed, promote stomach
Health.
Four, the health of liver and gallbladder function can be effectively facilitated.
Sample of the invention is even more to entrust Yi Shi inspection institute, carries out human test for 5 users, 5 users exist
After detecting for the first time, start to take sample of the invention, the ingot that every morning, noon and evening, taking dose was 500mg respectively
The medicament of agent or 30c.c are each primary, and are detected once again, as a result as follows:
1st user is 62 years old women, carries out 3 inspections altogether for liver function test (GOT/AST and GPT/ALT)
It surveys, as a result as follows:
By above-mentioned test result, it can be seen that, phytochemicals constituent provided by the present invention can effectively reduce bran oxalacetic acid
Turn amino ferment, is reduced to the 43U/L of standard from excessive 55U/L originally, and can effectively reduce bran pyruvic acid and turn amino ferment
Element is reduced to the 25U/L of standard from excessive 73U/L originally, it can be seen that the phytochemicals constituent can make liver function more strong
Health.
2nd user is 40 years old male, for liver function test (GPT/ALT) and alcoholic hepatitis (γ-
G.T. 3 detections) are carried out altogether, as a result as follows:
By above-mentioned test result, it can be seen that, phytochemicals constituent provided by the present invention can effectively reduce bran pyruvic acid
Turn amino ferment, be reduced to the 33U/L of standard from excessive 85U/L originally, and can effectively reduce bran ammonia and turn sour ferment, from original
This 57U/L is reduced to 51U/L, it can be seen that the phytochemicals constituent can make liver function more healthy.
3rd user is 62 years old male, for liver and gallbladder function (S-GOT (AST), S-GPT (ALT) and Alk-p
(adult)) 2 detections are carried out altogether, as a result as follows:
By above-mentioned test result, it can be seen that, phytochemicals constituent provided by the present invention can effectively reduce asparagus fern amino
Acid is greatly lowered as 60U/L from serious excessive 153U/L originally, and can effectively reduce the third amino acid and turn enzyme, from originally
Serious excessive 195U/L is greatly lowered to be reduced in addition, can effectively reduce alkaline phosphatase from script 86IU/L for 74U/L
For 73IU/L, it can be seen that the phytochemicals constituent can make liver and gallbladder function more healthy.
4th user is 39 years old male, carries out 2 altogether for hepato-biliary function inspection (SGOT, SGPT and γ-G.T.)
Secondary detection, as a result as follows:
By above-mentioned test result, it can be seen that, phytochemicals constituent provided by the present invention can effectively reduce bran propylhomoserin grass
Acid turns amine ferment, is reduced to the 30U/L of standard from excessive 56U/L originally, and can effectively reduce alanine oxalic acid and turn amine ferment
Element is greatly lowered from serious excessive 100U/L originally as 54U/L, in addition, can effectively reduce bran fish or meat paste base turns victory base ferment, from
Originally serious excessive 173IU/L is greatly lowered as 158IU/L, it can be seen that the phytochemicals constituent can make hepato-biliary function more
Add health.
5th user is 44 years old male, carries out 2 inspections altogether for uric acid (URCA) and total bilirubin (TBIL)
It surveys, as a result as follows:
By above-mentioned test result, it can be seen that, phytochemicals constituent provided by the present invention can effectively reduce uric acid, from original
This serious excessive 537.00umol/L is greatly lowered as 469.00umol/L, and can effectively reduce total bilirubin, from original
This serious excessive 41.00umol/L is greatly lowered as 36.30umol/L, it can be seen that the phytochemicals constituent can make liver and gallbladder
Function is more healthy.
It is the flow chart of the second preferred embodiment of the invention it is noted that please referring to shown in Fig. 2, it is of the invention
Second preferred embodiment is with the aforementioned maximum difference of first preferred embodiment, in second of plasma air sterilisation step
Afterwards, a misting cooling step is further included: by the filling grade semi-finished stocks to carry out being cooled to powder by spraying, and in this
After misting cooling step, an encapsulation finished product step has been further included: the grade semi-finished stocks after cooling are encapsulated as finished product.
The above, a preferred embodiment only of the invention can not limit patent protection of the invention with it
Range；I.e. big equivalent changes and modifications made according to the patent scope of the present invention, should still belong to patent protection of the invention
In range.
Claims (8)
1. a kind of phytochemicals manufacturing method, which is characterized in that include the following steps:
Material preparation step: preparing a plurality of raw materials, which includes Radix Glycyrrhizae, ginseng, ganoderma lucidum, fructus lycii, globe artichoke and Poria cocos；
Small molecule step: the grade raw materials are put into a catalytic unit with by the grade raw materials small molecule；
Batching step: the raw material after small molecule is subjected to ingredient to scale；
Mixing step: the raw material after ingredient being heated to sterilize, and is stirred, and is tool ammonia by the raw material decomposes such as this
The semi-finished product of base acid；
Constant temperature stands step: semi-finished stock being stood 30 days~180 days, converts the grade semi-finished stocks voluntarily, is promoted former
Material, which decomposes, makes it be converted to amino acid and polypeptide, small-molecular peptides, promotes absorption of human body.
2. phytochemicals manufacturing method as described in claim 1, which is characterized in that in mixing step, by the raw material after ingredient
Add water and be heated to 100 DEG C to be sterilized, while adding probiotics, ionizes the grade raw materials.
3. phytochemicals manufacturing method as described in claim 1, which is characterized in that after mixing step, further included a cooling
Step: semi-finished stock is cooled to 30 DEG C~50 DEG C, after cooling step, further includes a chelation step: after cooling
Semi-finished stock tinning, and chelating conversion reaction is carried out with 30 DEG C~50 DEG C constant temperature stirrings.
4. phytochemicals manufacturing method as claimed in claim 3, which is characterized in that after chelation step, further included one first
Secondary plasma air disinfection step: by the semi-finished stock after tinning in standing space with plasma air bactericidal purifying vehicle
Between, it after constant temperature stands step, has further included a sampling Detection step: the grade semi-finished stocks is sampled detection, sampled
Detection project includes total hydrolysis amino acid composition analyte detection, SOD like activity content detection, content of beary metal
Detection, aerobic plate count detection and antibacterial tests detection, after sampling Detection step, have further included second of plasma air
Sterilisation step: by the equal semi-finished stocks of filling space in standing space with plasma air bactericidal purifying workshop.
5. phytochemicals manufacturing method as claimed in claim 4, which is characterized in that in second of plasma air sterilisation step
Afterwards, it further includes an assembly line encapsulation step: the filling grade semi-finished stocks being subjected to assembly line encapsulation, are encapsulated in assembly line
After step, further include a filling finished product step: filling finished product is made in the grade semi-finished stocks after assembly line is encapsulated, the filling
Dress up product be liquid, glue, powdery or ingot shape further included a steam sterilization step after filling finished product step: by it is filling at
Product are with 100 DEG C of steam sterilizations, after steam sterilization step, further include a packed products step: by the filling finished product after sterilization
It is packed.
6. phytochemicals manufacturing method as claimed in claim 4, which is characterized in that in second of plasma air sterilisation step
Afterwards, a misting cooling step is further included: by the filling grade semi-finished stocks to carry out being cooled to powder by spraying, and in this
After misting cooling step, an encapsulation finished product step has been further included: the grade semi-finished stocks after cooling are encapsulated as finished product.
7. a kind of phytochemicals constituent, which is characterized in that its raw material includes Radix Glycyrrhizae, ginseng, ganoderma lucidum, fructus lycii, globe artichoke and Fu
Siberian cocklebur, which includes: Tian Men Dong Hai amine, bran propylhomoserin, serine, histidine, glycine, crisp propylhomoserin, arginine,
Alanine, tyrosine, valine, methionine, isoleucine, leucine, from propylhomoserin and proline.
8. phytochemicals constituent as claimed in claim 7, which is characterized in that the every 100mL of the phytochemicals constituent includes:
150-165mg Men Dong Hai amine, 65-75mg bran propylhomoserin, 5-15mg serine, 0.5-2mg histidine, 5-15mg glycine,
2.5-7.5mg shortcake propylhomoserin, 10-20mg arginine, 15-25mg alanine, 2-5mg tyrosine, 7-17mg valine, 3-8mg first
Methyllanthionine, 1-5mg isoleucine, 2-8mg leucine, 0.5-4.5mg are from propylhomoserin and 10-30mg proline.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW107116884 | 2018-05-17 | ||
| TW107116884A TWI675667B (en) | 2018-05-17 | 2018-05-17 | Phytochemical composition and method of producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110495604A true CN110495604A (en) | 2019-11-26 |
Family
ID=68584932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811286805.1A Pending CN110495604A (en) | 2018-05-17 | 2018-10-31 | Plant element composition and its producing method |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN110495604A (en) |
| TW (1) | TWI675667B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116651533A (en) * | 2023-05-26 | 2023-08-29 | 苏建桦 | Composition for increasing telomere length and method for preparing the same |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1738905A (en) * | 2002-12-05 | 2006-02-22 | 弘林通产株式会社 | Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof |
| CN1985864A (en) * | 2005-12-19 | 2007-06-27 | 黄振华 | Medicine composition of glycyrrhizic acid or its salt, ginseng and glossy ganoderma |
| US20120034238A1 (en) * | 2010-08-03 | 2012-02-09 | Asia Hepato Gene Co. | Compositions and methods for treating hepatitis virus infection |
| CN105146379A (en) * | 2015-08-05 | 2015-12-16 | 威海紫光科技园有限公司 | Preparation method of fig enzyme |
| CN105996008A (en) * | 2016-06-24 | 2016-10-12 | 苏剑锋 | Enzyme product containing ginseng and polygonatum sibiricum and preparation method of enzyme product |
| CN106509578A (en) * | 2016-10-27 | 2017-03-22 | 广西仙芝堂健康产业有限公司 | Production method of instant ganoderma lucidum-poria cocos compound healthy beverage |
| CN107427055A (en) * | 2016-01-06 | 2017-12-01 | 哈斯贝兰思 | The device of subtle powder smash Red Ginseng is manufactured, for being decomposed by biochemical fermentation and enzyme and the Red Ginseng concentrate of red ginseng active ingredient uptake ratio and the preparation method of red ginseng liquid of maximizing by physics mode |
-
2018
- 2018-05-17 TW TW107116884A patent/TWI675667B/en active
- 2018-10-31 CN CN201811286805.1A patent/CN110495604A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1738905A (en) * | 2002-12-05 | 2006-02-22 | 弘林通产株式会社 | Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof |
| CN1985864A (en) * | 2005-12-19 | 2007-06-27 | 黄振华 | Medicine composition of glycyrrhizic acid or its salt, ginseng and glossy ganoderma |
| US20120034238A1 (en) * | 2010-08-03 | 2012-02-09 | Asia Hepato Gene Co. | Compositions and methods for treating hepatitis virus infection |
| WO2012016429A1 (en) * | 2010-08-03 | 2012-02-09 | Asia Hepato Gene Co. | Compositions and methods for treating hepatitis virus infection |
| CN102884079A (en) * | 2010-08-03 | 2013-01-16 | 华肝基因股份有限公司 | Compositions and methods for treating hepatitis virus infection |
| CN105146379A (en) * | 2015-08-05 | 2015-12-16 | 威海紫光科技园有限公司 | Preparation method of fig enzyme |
| CN107427055A (en) * | 2016-01-06 | 2017-12-01 | 哈斯贝兰思 | The device of subtle powder smash Red Ginseng is manufactured, for being decomposed by biochemical fermentation and enzyme and the Red Ginseng concentrate of red ginseng active ingredient uptake ratio and the preparation method of red ginseng liquid of maximizing by physics mode |
| CN105996008A (en) * | 2016-06-24 | 2016-10-12 | 苏剑锋 | Enzyme product containing ginseng and polygonatum sibiricum and preparation method of enzyme product |
| CN106509578A (en) * | 2016-10-27 | 2017-03-22 | 广西仙芝堂健康产业有限公司 | Production method of instant ganoderma lucidum-poria cocos compound healthy beverage |
Non-Patent Citations (11)
| Title |
|---|
| 于建敏等: "《痛风饮食宜忌速查》", 30 November 2017, 吉林科学技术出版社 * |
| 周为群等: "《现代生活与化学》", 28 February 2014, 苏州大学出版社 * |
| 徐义雄: "《营养素私人定制教程》", 31 December 2017, 暨南大学出版社 * |
| 徐荣翰: "《干燥设备设计》", 31 May 1986, 上海科学技术出版社 * |
| 易磊: "《妙用本草良方》", 31 March 2017, 中医古籍出版社 * |
| 武谦虎: "《从生活中学中医速查全书》", 31 January 2014, 中国医药科技出版社 * |
| 汪秋航等: "《病毒性肝炎药物手册》", 30 September 1996, 湖南科学技术出版社 * |
| 熊曼琪: "《伤寒学》", 30 June 2006, 中国中医药出版社 * |
| 蒋力华等: "《中国人参文化》", 31 August 1995, 吉林科技出版社 * |
| 蔡宝昌等: "《中药制剂前处理新技术与新设备》", 30 November 2005, 中国医药科技出版社 * |
| 马清钧: "《常用中药现代研究与临床》", 31 July 1995, 天津科技翻译出版公司 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116651533A (en) * | 2023-05-26 | 2023-08-29 | 苏建桦 | Composition for increasing telomere length and method for preparing the same |
| CN116651533B (en) * | 2023-05-26 | 2024-06-11 | 苏建桦 | Preparation method of composition for improving telomere length |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI675667B (en) | 2019-11-01 |
| TW201946643A (en) | 2019-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107432397A (en) | A kind of solid beverage of ginseng small-molecular peptides compounding and preparation method thereof | |
| CN102246961B (en) | Ganoderma gingko functional food, preparation method and application | |
| CN103571704A (en) | Preparation method of agilawood health-care wine and agilawood wine thereof | |
| CN109730217A (en) | A kind of fungi beverage and preparation method thereof | |
| CN110495604A (en) | Plant element composition and its producing method | |
| CN105902567A (en) | Preparation method of Tibetan medicine composition seven-mineral ash | |
| CN112076266A (en) | Ganoderma lucidum spore powder buccal tablet and preparation method thereof | |
| CN103652840A (en) | Production method for cordyceps militaris lung-moistening tablet | |
| CN106176855A (en) | A kind of concocting method of Radix Ginseng Rubra decoction pieces | |
| CN102246960A (en) | Chinese caterpillar fungus ginkgo functional food, preparation method and application | |
| CN113975341A (en) | Traditional Chinese medicine fermented paste formula for invigorating spleen to eliminate dampness and preparation method thereof | |
| CN103417616B (en) | A kind of anti-wart Traditional Chinese medicine essence and extraction process thereof | |
| CN103100015B (en) | Medicament for treating disease of respiratory system, as well as preparation method and application thereof | |
| CN109453321A (en) | A kind of enriching essence and nourishing marrow, nti-freckle expellant medicament ginseng rhizoma polygonati slice prescription and preparation method thereof | |
| CN106418516A (en) | Preparation method of fresh dendrobium nobile preparation | |
| CN107812147A (en) | A kind of pharmaceutical composition with anti-acne effect | |
| CN101214299B (en) | Spray coating type empyrosis medicinal liquor and preparation thereof | |
| CN1283246C (en) | Complex rheum officinale-radix scutellariae extract injecta for treating acute pancreatitis and preparing method thereof | |
| CN1370465A (en) | Vigor-giving health beverage | |
| CN1965978A (en) | Natural botanical extraction liquid for preventing and treating epidemic febrile disease of birds and livestock and method for preparing same | |
| CN1370464A (en) | Vital energy and blood balancing health beverage | |
| CN107536873A (en) | A kind of Chinese medicine preparation for treating thrush | |
| Gargoum | A HUMAN STUDY ON THE EFFECT OF ALHAGI MAURORUM (CAMEL THORN) ON PATIENTS SUFFERING FROM HEPATITIS B VIRUS | |
| CN108853273A (en) | Anti-aging medicament and preparation method | |
| CN104119576B (en) | A kind of Radix Morindae Officinalis with regulation tumor microenvironment effect and Rhizoma Polygonati complex polysaccharide and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191126 |